HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicolai Härtel Selected Research

Nicolai Härtel Research Topics

Disease

6Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2016
6Neoplasms (Cancer)
01/2022 - 11/2006
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
02/2012 - 11/2006
2Leukemia
05/2008 - 11/2006
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Carcinoma (Carcinomatosis)
06/2020
1Adenocarcinoma
12/2019
1Disease Progression
01/2019
1Adenoma (Adenomas)
10/2017
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2008

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
01/2022 - 11/2006
3Imatinib Mesylate (Gleevec)FDA Link
02/2012 - 11/2006
2Biomarkers (Surrogate Marker)IBA
07/2019 - 05/2008
2Bevacizumab (Avastin)FDA Link
07/2019 - 01/2016
2nilotinibFDA Link
02/2012 - 05/2008
1Biological ProductsIBA
01/2022
1Trastuzumab (Herceptin)FDA Link
12/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2019
1Aryl Hydrocarbon Receptor Nuclear TranslocatorIBA
07/2019
1Immune Checkpoint InhibitorsIBA
01/2019
1Cell-Free Nucleic AcidsIBA
01/2019
1Calcibiotic Root Canal SealerIBA
10/2017
1Messenger RNA (mRNA)IBA
10/2017
1Dasatinib (BMS 354825)FDA Link
02/2012
1Tyrosine Kinase InhibitorsIBA
02/2012
1Phosphotransferases (Kinase)IBA
05/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2006
12-acylglycerophosphate acyltransferaseIBA
11/2006

Therapy/Procedure

5Therapeutics
06/2020 - 01/2016
2Drug Therapy (Chemotherapy)
01/2022 - 01/2022
1Aftercare (After-Treatment)
01/2022
1Polypharmacy
06/2020
1Operative Surgical Procedures
06/2020
1Immunotherapy
01/2019
1Combination Drug Therapy (Combination Chemotherapy)
01/2016